Ocular toxicity of hydroxychloroquine - PubMed (original) (raw)
Review
. 2008 May-Jun;23(3):201-9.
doi: 10.1080/08820530802049962.
Affiliations
- PMID: 18432546
- DOI: 10.1080/08820530802049962
Review
Ocular toxicity of hydroxychloroquine
Rodney Tehrani et al. Semin Ophthalmol. 2008 May-Jun.
Abstract
This review summarizes the current literature regarding the ocular complications of hydroxychloroquine. Hydroxychloroquine has been used since the 1950s for the treatment of various rheumatic and dermatologic diseases. Hydroxychloroquine can cause ocular toxicity, with the most serious being an irreversible retinopathy. At the present time, no "gold standard" exists for identification of the ocular toxicity prior to its development. This has led to controversy regarding the recommendations for ophthalmologic examinations for screening patients on hydroxychloroquine.
Similar articles
- A novel method for screening the multifocal electroretonogram in patients using hydroxychloroquine.
Chang WH, Katz BJ, Warner JE, Vitale AT, Creel D, Digre KB. Chang WH, et al. Retina. 2008 Nov-Dec;28(10):1478-86. doi: 10.1097/IAE.0b013e318181445b. Retina. 2008. PMID: 18997610 - The Demise of the Bull's Eye (Screening for Hydroxychloroquine Retinopathy).
Marmor MF. Marmor MF. Retina. 2016 Oct;36(10):1803-5. doi: 10.1097/IAE.0000000000001151. Retina. 2016. PMID: 27388736 No abstract available. - [The ERG contribution in early diagnosis of chloroquine and hydroxychloroquine maculopathy].
Karkanová M, Matusková V, Vlková E, Dosková H, Uhmannová R. Karkanová M, et al. Cesk Slov Oftalmol. 2010 Apr;66(2):62-6. Cesk Slov Oftalmol. 2010. PMID: 20925239 Czech. - Hydroxychloroquine retinopathy: A review of imaging.
Pandya HK, Robinson M, Mandal N, Shah VA. Pandya HK, et al. Indian J Ophthalmol. 2015 Jul;63(7):570-4. doi: 10.4103/0301-4738.167120. Indian J Ophthalmol. 2015. PMID: 26458473 Free PMC article. Review. - Ocular toxicity of hydroxychloroquine.
Yam JC, Kwok AK. Yam JC, et al. Hong Kong Med J. 2006 Aug;12(4):294-304. Hong Kong Med J. 2006. PMID: 16912357 Review.
Cited by
- Effect of hydroxychloroquine blood concentration on the efficacy and ocular toxicity of systemic lupus erythematosus.
Liu PC, Luo SL, Lv MN, Wang Y, Li JB, Yu SJ, Wu R. Liu PC, et al. Sci Rep. 2024 Apr 1;14(1):7674. doi: 10.1038/s41598-024-58391-2. Sci Rep. 2024. PMID: 38561370 Free PMC article. - A study to determine the effect of hydroxychloroquine (HCQ) on central corneal thickness (CCT) in patients with rheumatoid arthritis (RA).
Jaichander RC, Thomas RK, Shobha V. Jaichander RC, et al. Indian J Ophthalmol. 2024 Feb 1;72(2):270-274. doi: 10.4103/IJO.IJO_3052_22. Epub 2023 Dec 15. Indian J Ophthalmol. 2024. PMID: 38099363 Free PMC article. - Ophthalmologic implications to consider when using hydroxychloroquine to treat COVID-19 and induced arthritis.
Zeppieri M. Zeppieri M. World J Exp Med. 2023 Sep 20;13(4):95-98. doi: 10.5493/wjem.v13.i4.95. eCollection 2023 Sep 20. World J Exp Med. 2023. PMID: 37767541 Free PMC article. - Decreased perifoveal ganglion cell complex thickness - a first sign for macular damage in patients using hydroxychloroquine.
Agcayazi SBE, Gurlu V, Alacamli G. Agcayazi SBE, et al. Rom J Ophthalmol. 2023 Apr-Jun;67(2):146-151. doi: 10.22336/rjo.2023.26. Rom J Ophthalmol. 2023. PMID: 37522014 Free PMC article. - The impact of oral and systemic medications on the eye.
Sabherwal S, Mohamed-Ahmed AHA. Sabherwal S, et al. Community Eye Health. 2023;36(118):14-16. Epub 2023 May 22. Community Eye Health. 2023. PMID: 37273814 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical